Please login to the form below

Not currently logged in
Email:
Password:

GW Pharmaceuticals

This page shows the latest GW Pharmaceuticals news and features for those working in and with pharma, biotech and healthcare.

Orchard surpasses IPO expectations, raising $200m

Orchard surpasses IPO expectations, raising $200m

flow. Orchard now joins a cluster of European biotechs, including the likes of GW Pharmaceuticals and Genmab, that are worth 1bn or more.

Latest news

  • The year of the blockbuster The year of the blockbuster

    Emanating from the pipelines of global pharma giants like Novartis, Johnson &Johnson and Pfizer, as well companies such as Denmark’s Novo Nordisk and Indivior and GW Pharmaceuticals, both of the ... Epidiolex from GW Pharmaceuticals:With a PDUFA date

  • Cancer pain: opioids set to dominate Cancer pain: opioids set to dominate

    Phase III: opioid agonists. GW Pharmaceuticals has developed a buccal spray known as nabiximols or Sativex, which comprises delta-9-tetrahydrocannabinol (27mg/mL) and cannabidiol (25mg/mL), as an analgesic agent ... WEX Pharmaceuticals is conducting a

  • Almirall launches Sativex in Italy Almirall launches Sativex in Italy

    The drug, developed by GW Pharmaceuticals, was approved by Italian authorities in May and comes to the market with a reimbursed priced that GW said was “ consistent with the reimbursed … price ... Sativex has been given a rolling launch in Europe,

  • GW Pharma says German Sativex pricing GW Pharma says German Sativex pricing "unacceptable"

    GW Pharma says German Sativex pricing "unacceptable". May pull MS drug from market. ... GW Pharmaceuticals and partner Almirall have said they may pull Sativex from the market in Germany after failing to agree a price for the drug with the national

  • Almirall files cannabis-based MS drug Sativex in additional EU markets

    by GW Pharmaceuticals. ... It is manufactured by GW Pharma under Home Office licence at an undisclosed location in the UK, and represents the first new therapeutic class to treat spasticity in over 10 years.

More from news
Approximately 0 fully matching, plus 44 partially matching documents found.

Latest appointments

  • GW Pharmaceuticals strengthens research and development team GW Pharmaceuticals strengthens research and development team

    GW Pharmaceuticals strengthens research and development team. Appoints Dr Volker Knappertz and Professor Ben Whalley. ... GW Pharmaceuticals has appointed Dr Volker Knappertz (pictured right) as its chief medical officer (CMO), a role that will see him

  • GW Pharmaceuticals promotes Adam George to MD GW Pharmaceuticals promotes Adam George to MD

    GW Pharmaceuticals promotes Adam George to MD. And Scott Giacobello joins as chief financial officer. ... UK biopharma company GW Pharmaceuticals has promoted chief financial officer Adam George to UK managing director.

  • GW hires Pfizer’s Kenneth Sommerville GW hires Pfizer’s Kenneth Sommerville

    GW hires Pfizer’ s Kenneth Sommerville. Appointed VP clinical research at company specialising in cannabinoids. ... Dr Kenneth Sommerville has left his role at pharma giant Pfizer to join GW Pharma.

More from appointments
Approximately 1 fully matching, plus 2 partially matching documents found.

Latest from PMHub

  • Medical Marijuana Market to Soar at 36% CAGR to 2024

    Some of the prominent industry players in medical marijuana market are Canopy Growth, Aurora Cannabis, Inc., Medical Marijuana, Inc., GW Pharmaceuticals, Aphria, Inc., CanniMed Ltd., Tilray, Emerald Health Therapeutics, and MedReleaf

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
OPEN Access Consulting

OPEN Access Consulting is a specialist market access agency within the OPEN Health Group. As value communications experts we specialise...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics